These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 291752)

  • 21. Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats.
    Carr BI
    Cancer Res; 1987 Nov; 47(21):5577-83. PubMed ID: 2889526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinate polypeptide expression during hepatocarcinogenesis in male F-344 rats: comparison of the Solt-Farber and Reddy models.
    Wirth PJ; Rao MS; Evarts RP
    Cancer Res; 1987 Jun; 47(11):2839-51. PubMed ID: 3552207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
    Maeura Y; Weisburger JH; Williams GM
    Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early initiating and promoting effects in 2-AAF-induced rat liver carcinogenesis: an immunohistochemical study.
    Hadjiolov N; Bitsch A; Neumann HG
    Cancer Lett; 1995 Nov; 98(1):39-46. PubMed ID: 8529204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
    De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
    Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas.
    Ledda-Columbano GM; Perra A; Loi R; Shinozuka H; Columbano A
    Cancer Res; 2000 Feb; 60(3):603-9. PubMed ID: 10676643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential morphologic changes during methapyrilene-induced hepatocellular carcinogenesis in rats.
    Reznik-Schüller HM; Gregg M
    J Natl Cancer Inst; 1983 Nov; 71(5):1021-31. PubMed ID: 6580478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental studies on hepatic cirrhosis and hepatocarcinogenesis. II. Influence of cirrhotic liver on 2-FAA hepatocarcinogenesis in rats.
    Shimizu A
    Acta Pathol Jpn; 1986 Jul; 36(7):1039-48. PubMed ID: 3529810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concanavalin A agglutination of cells from primary hepatocellular carcinomas and hepatic nodules induced by N-2-fluorenylacetamide.
    Becker FF; Shurgin A
    Cancer Res; 1975 Oct; 35(10):2879-83. PubMed ID: 168971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
    Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M
    Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential analysis of chemically induced hepatoma development in rats by two dimensional electrophoresis.
    Wirth PJ; Benjamin T; Schwartz DM; Thorgeirsson SS
    Cancer Res; 1986 Jan; 46(1):400-13. PubMed ID: 3940206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis.
    Hirota N; Williams GM
    Am J Pathol; 1979 May; 95(2):317-28. PubMed ID: 222150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nature of early appearing, carcinogen-induced liver lesions to iron accumulation.
    Williams GM; Klaiber M; Parker SE; Farber E
    J Natl Cancer Inst; 1976 Jul; 57(1):157-65. PubMed ID: 1003498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of DNA adducts in putative premalignant hepatic nodules and nontarget tissues of rats during 2-acetylaminofluorene carcinogenesis.
    Gupta RC; Earley K; Becker FF
    Cancer Res; 1988 Sep; 48(18):5270-4. PubMed ID: 3409250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
    Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
    Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and transplantation of hepatocytes from livers of carcinogen-treated rats.
    Miller SB; Pretlow TP; Scott JA; Pretlow TG
    J Natl Cancer Inst; 1982 May; 68(5):851-7. PubMed ID: 6121927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression in hepatocarcinogenesis: differences in growth and behavior of transplants of early and later hepatocyte nodules in the rat spleen.
    Tatematsu M; Lee G; Hayes MA; Farber E
    Cancer Res; 1987 Sep; 47(17):4699-705. PubMed ID: 3621164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High susceptibility of specific inbred colonies of rats to n-2-fluorenylacetamide-induced hepatocarcinogenesis.
    Ohmori T; Kondo M; Tabei R
    Gan; 1983 Dec; 74(6):822-8. PubMed ID: 6667833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver.
    Tatematsu M; Nagamine Y; Farber E
    Cancer Res; 1983 Nov; 43(11):5049-58. PubMed ID: 6137276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.